KLRS · Kalaris Therapeutics, Inc.
$3.39
+0.05 (+1.50%)
At close · Jul 29
Market Cap
$80.89M
Shares
23.79M
Kalaris Therapeutics, Inc. Earnings Call Transcripts
Every quarterly earnings call for Kalaris Therapeutics, Inc. (KLRS) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Earnings call
FY22 · Q4
2023-02-15
Kalaris Therapeutics, Inc. Q4 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Kalaris Therapeutics, Inc. Q3 FY2022 Earnings Call
Diluted EPS
$-11.50
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-09-02
Kalaris Therapeutics, Inc. Q2 FY2020 Earnings Call
Revenue
$165,000
Audio
Transcript
Slides
8-K10-Q
Showing 1–3 of 3 earnings calls